Indaptus Therapeutics Inc INDP
$1.29 $0.09 (6.52%) 1D
Last Updated: Aug 21, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
INDP Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Indaptus Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Indaptus Therapeutics Inc. Stock Analysis INDP
United States Health Care Micro Cap Indaptus Therapeutics, Inc. is a clinical biotechnology company. The company is headquartered in New York City, New York and currently employs 5 full-time employees. The company went IPO on 2012-09-07. The Company’s approach is based on the hypothesis that activation of both innate and adaptive immune cells and pathways and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system-activating signals that can be administered safely intravenously (i.v.). Its technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria producing a multiple Toll-like receptor (TLR), Nucleotide oligomerization domain (NOD)-like receptor (NLR) and Stimulator of interferon genes (STING) agonist Decoy platform. The firm's lead clinical candidate is Decoy20. Its Decoy product candidates have also produced significant single agent activity against chronic hepatitis B virus (HBV) and chronic human immunodeficiency virus (HIV) infections in pre-clinical models.
Indaptus Therapeutics Inc (INDP) Chart
Financial Metrics & Statements of Indaptus Therapeutics Inc (INDP)
FAQ's for Indaptus Therapeutics Inc (INDP)
- As of August 2026, Indaptus Therapeutics Inc INDP is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Indaptus Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Indaptus Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Indaptus Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Indaptus Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Indaptus Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Indaptus Therapeutics Inc (INDP)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
